Iris BioTechnologies CEO Simon Chin Will Discuss Big Data at the World's Largest Gathering for Laboratory Medicine at AACC 2014
Marketwire - Wed Jul 09, 8:18AM CDT
Iris BioTechnologies Inc. (OTCQB: IRSB) is a life sciences company and is a leader in the Invitro Diagnostic (IVD) industry.
Iris BioTechnologies Enables Personalized Precision Medicine and Wellness -- an Invited Presentation at the BIO 2014 International Convention
Marketwire - Wed Jun 25, 7:52AM CDT
Iris BioTechnologies Inc. (OTCQB: IRSB) is growing. This is the first news release since Iris's previous press release on April 18, 2014, announcing that Iris was a winner of the 2014 IAIR AWARDS, the Company was issued US patent 8,693,751, which enables and accelerates the practice of personalized precision medicine, and Iris was invited to present at the 2014 BIO International Convention, taking place June 23-26 in San Diego, California.